Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5324417 | 1.00 | USP2 (0.48) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| SCHEMBL31000531 | 0.83 | SLC7A5 (0.46) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| SCHEMBL1867465 | 0.83 | SLC7A5 (0.46) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| SCHEMBL1374284 | 0.83 | USP2 (0.52) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| SCHEMBL1867460 | 0.83 | SLC7A5 (0.46) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| SCHEMBL23924442 | 0.83 | SLC7A5 (0.46) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| SCHEMBL2367281 | 0.83 | SLC7A5 (0.46) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| SCHEMBL497584 | 0.83 | USP2 (0.52) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| SCHEMBL1867463 | 0.83 | SLC7A5 (0.46) | USP2SLCO1B1SLC7A5TSHRSLC1A3 | |
| D,L-Threo-3-Hydroxyaspartic Acid SCHEMBL5513561 | 0.79 | TSHR (0.45) | USP2SLCO1B1SLC7A5TSHRSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | USP2 3792/4885SLCO1B1 3054/4885SLC7A5 3712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.